Carcinomatous Pericarditis in 3 Breast Cancer Patients with Long-Term Survival

por Konishi, Takanori, Nakamura, Rikiya, Yamamoto, Naohito, Onai, Yasuhide, Okada, Toshi, Itami, Makiko, Miyazaki, Masaru
Publicado 2012

Does Routine Follow-Up after Patients Have Completed Adjuvant Therapy for Early-Stage Breast Cancer at a Cancer Center Improve Prognosis?

por Nakamura, Rikiya, Hayama, Shouko, Etou, Ryoutarou, Miyaki, Toshiko, Oshida, Keiko, Oshida, Masaki, Itou, Yashushi, Kou, Tetsumori, Yamamoto, Naohito
Publicado 2022

Synchronous early-stage breast cancer and axillary follicular lymphoma diagnosed by core needle biopsy: A case report

por Eto, Ryotaro, Nakamura, Rikiya, Yamamoto, Naohito, Miyaki, Toshiko, Hayama, Shoko, Sonoda, Itaru, Itami, Makiko, Tsujimura, Hideki, Hashimoto, Hideyuki, Otsuka, Masayuki
Publicado 2022

Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup...

por Masuda, Norikazu, Inoue, Kenichi, Nakamura, Rikiya, Rai, Yoshiaki, Mukai, Hirofumi, Ohno, Shinji, Hara, Fumikata, Mori, Yuko, Hashigaki, Satoshi, Muramatsu, Yasuaki, Nagasawa, Takashi, Umeyama, Yoshiko, Huang, Xin, Iwata, Hiroji
Publicado 2018

The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patients

por Hayama, Shouko, Nakamura, Rikiya, Ishige, Takayuki, Sangai, Takafumi, Sakakibara, Masahiro, Fujimoto, Hiroshi, Ishigami, Emi, Masuda, Takahito, Nakagawa, Ayako, Teranaka, Ryotaro, Ota, Satoshi, Itoga, Sakae, Yamamoto, Naohito, Nagashima, Takeshi, Otsuka, Masayuki
Publicado 2023

Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy

por Iwata, Hiroji, Yamamoto, Yutaka, Sakai, Takehiko, Hasegawa, Yoshie, Nakamura, Rikiya, Akabane, Hiromitsu, Ohtani, Shoichiro, Kashiwaba, Masahiro, Taira, Naruto, Toyama, Tatsuya, Fujisawa, Tomomi, Masuda, Norikazu, Shibahara, Yukiko, Sasano, Hironobu, Yamaguchi, Takuhiro
Publicado 2023

PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Recepto...

por Iwata, Hiroji, Im, Seock-Ah, Masuda, Norikazu, Im, Young-Hyuck, Inoue, Kenichi, Rai, Yoshiaki, Nakamura, Rikiya, Kim, Jee Hyun, Hoffman, Justin T., Zhang, Ke, Giorgetti, Carla, Iyer, Shrividya, Schnell, Patrick T., Bartlett, Cynthia Huang, Ro, Jungsil
Publicado 2017

Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination Therapy

por Shimomura, Akihiko, Yonemori, Kan, Yoshida, Masayuki, Yoshida, Teruhiko, Yasojima, Hiroyuki, Masuda, Norikazu, Aogi, Kenjiro, Takahashi, Masato, Naito, Yoichi, Shimizu, Satoru, Nakamura, Rikiya, Hamada, Akinobu, Michimae, Hirofumi, Hashimoto, Jun, Yamamoto, Harukaze, Kawachi, Asuka, Shimizu, Chikako, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado 2019

Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2–positive advanced or metastatic breast cancer: a multicenter,...

por Yamashita, Toshinari, Kawaguchi, Hidetoshi, Masuda, Norikazu, Kitada, Masahiro, Narui, Kazutaka, Hattori, Masaya, Yoshinami, Tetsuhiro, Matsunami, Nobuki, Yanagihara, Kazuhiro, Kawasoe, Teru, Nagashima, Takeshi, Bando, Hiroko, Yano, Hiroshi, Hasegawa, Yoshie, Nakamura, Rikiya, Kashiwaba, Masahiro, Morita, Satoshi, Ohno, Shinji, Toi, Masakazu
Publicado 2020

A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+...

por Masuda, Norikazu, Ohtani, Shoichiro, Takano, Toshimi, Inoue, Kenichi, Suzuki, Eiji, Nakamura, Rikiya, Bando, Hiroko, Ito, Yoshinori, Ishida, Kazushige, Yamanaka, Takashi, Kuroi, Katsumasa, Yasojima, Hiroyuki, Kasai, Hiroi, Takasuka, Tsuyoshi, Sakurai, Takaki, Kataoka, Tatsuki R., Morita, Satoshi, Ohno, Shinji, Toi, Masakazu
Publicado 2020

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer

por Sasada, Shinsuke, Kondo, Naoto, Hashimoto, Hiroya, Takahashi, Yuko, Terata, Kaori, Kida, Kumiko, Sagara, Yasuaki, Ueno, Takayuki, Anan, Keisei, Suto, Akihiko, Kanbayashi, Chizuko, Takahashi, Mina, Nakamura, Rikiya, Ishiba, Toshiyuki, Tsuneizumi, Michiko, Nishimura, Seiichiro, Naito, Yoichi, Hara, Fumikata, Shien, Tadahiko, Iwata, Hiroji
Publicado 2023

Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHA...

por Yamamoto, Yutaka, Yamashiro, Hiroyasu, Toh, Uhi, Kondo, Naoto, Nakamura, Rikiya, Kashiwaba, Masahiro, Takahashi, Masato, Tsugawa, Koichiro, Ishikawa, Takashi, Nakayama, Takahiro, Ohtani, Shoichiro, Takano, Toshimi, Fujisawa, Tomomi, Toyama, Tatsuya, Kawaguchi, Hidetoshi, Mashino, Kojiro, Tanino, Yuichi, Morita, Satoshi, Toi, Masakazu, Ohno, Shinji
Publicado 2020

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study

por Iwata, Hiroji, Masuda, Norikazu, Yamamoto, Yutaka, Fujisawa, Tomomi, Toyama, Tatsuya, Kashiwaba, Masahiro, Ohtani, Shoichiro, Taira, Naruto, Sakai, Takehiko, Hasegawa, Yoshie, Nakamura, Rikiya, Akabane, Hiromitsu, Shibahara, Yukiko, Sasano, Hironobu, Yamaguchi, Takuhiro, Sakamaki, Kentaro, Bailey, Helen, Cherbavaz, Diana B., Jakubowski, Debbie M., Sugiyama, Naoko, Chao, Calvin, Ohashi, Yasuo
Publicado 2018

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition

por Shimoi, Tatsunori, Nagai, Shigenori E., Yoshinami, Tetsuhiro, Takahashi, Masato, Arioka, Hitoshi, Ishihara, Mikiya, Kikawa, Yuichiro, Koizumi, Kei, Kondo, Naoto, Sagara, Yasuaki, Takada, Masahiro, Takano, Toshimi, Tsurutani, Junji, Naito, Yoichi, Nakamura, Rikiya, Hattori, Masaya, Hara, Fimikata, Hayashi, Naoki, Mizuno, Toshiro, Miyashita, Minoru, Yamashita, Nami, Yamanaka, Takashi, Saji, Shigehira, Iwata, Hiroji, Toyama, Tatsuya
Publicado 2020

Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition

por Shimoi, Tatsunori, Nagai, Shigenori E., Yoshinami, Tetsuhiro, Takahashi, Masato, Arioka, Hitoshi, Ishihara, Mikiya, Kikawa, Yuichiro, Koizumi, Kei, Kondo, Naoto, Sagara, Yasuaki, Takada, Masahiro, Takano, Toshimi, Tsurutani, Junji, Naito, Yoichi, Nakamura, Rikiya, Hattori, Masaya, Hara, Fimikata, Hayashi, Naoki, Mizuno, Toshiro, Miyashita, Minoru, Yamashita, Nami, Yamanaka, Takashi, Saji, Shigehira, Iwata, Hiroji, Toyama, Tatsuya
Publicado 2021

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition

por Terada, Mitsuo, Ito, Aki, Kikawa, Yuichiro, Koizumi, Kei, Naito, Yoichi, Shimoi, Tatsunori, Ishihara, Mikiya, Yamanaka, Takashi, Ozaki, Yukinori, Hara, Fumikata, Nakamura, Rikiya, Hattori, Masaya, Miyashita, Minoru, Kondo, Naoto, Yoshinami, Tetsuhiro, Takada, Masahiro, Matsumoto, Koji, Narui, Kazukata, Sasada, Shinsuke, Iwamoto, Takayuki, Hosoda, Mitsuchika, Takano, Yuko, Oba, Takaaki, Sakai, Hitomi, Murakami, Akari, Higuchi, Toru, Tsuchida, Junko, Tanabe, Yuko, Shigechi, Tomoko, Tokuda, Emi, Harao, Michiko, Kashiwagi, Shinichiro, Mase, Junichi, Watanabe, Junichiro, Nagai, Shigenori E., Yamauchi, Chikako, Yamamoto, Yutaka, Iwata, Hiroji, Saji, Shigehira, Toyama, Tatsuya
Publicado 2023